CancerX Startup Accelerator
CancerX is a public-private partnership accelerator, launched in 2023 under HHS InnovationX and hosted by Moffitt Cancer Center and Advocate Health, that runs an annual cohort-based program and community platform to connect early-stage digital health startups with healthcare, pharma, and investor champions for cancer care innovation.
- Company typePrivate
- Founded2023
- HeadquartersTampa, United States
- Headcount—
- GTM typeB2B
- OfferingServices
What CancerX Startup Accelerator does
CancerX is a public-private partnership accelerator and community platform launched in 2023 to accelerate digital innovation in oncology. Founded in coordination with HHS's Office of the Assistant Secretary for Technology Policy as part of the InnovationX program, it is hosted by two founding anchor members, Moffitt Cancer Center and Advocate Health, and operates from Tampa, Florida. The organization runs an annual four-month accelerator cohort (February through July) that selects 12-16 early-stage digital health startups per year through a competitive process, matching each with at least two Champion organizations (health systems, pharmaceutical companies, or investors) who provide mentorship, pilot opportunities, and pathways to commercial agreements. CancerX complements the accelerator with the Constellation online community platform, a Data Sprint initiative partnering with CMMI, NCI, FDA, and ONC to advance oncology data standards, and a Financial Toxicity initiative providing digital tools such as a Digital Navigation ROI Calculator and a Digitally Enabled Patient Navigation Blueprint for health systems. The 2024 inaugural cohort's 16 startups collectively raised over $42 million in venture funding, signed 9 health system contracts, and employed 234 individuals; the 2025 cohort reported 100% of startups advancing at least one strategic opportunity. Membership is offered through tiered annual subscriptions (Foundational, Premier Contributor, Thought Leader, Innovation Leader, Innovation Catalyst), and federal partnership support is provided via HHS. As a consortium-style nonprofit entity with a core team of approximately 12-15 staff, CancerX is structurally a convening and ecosystem-orchestration organization rather than a product or technology vendor.
CancerX Startup Accelerator firmographics
Firmographics- Name
- CancerX Startup Accelerator
- Legal name
- CancerX
- Website
- https://cancerx.health
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Short description
- CancerX is a public-private partnership accelerator, launched in 2023 under HHS InnovationX and hosted by Moffitt Cancer Center and Advocate Health, that runs an annual cohort-based program and community platform to connect early-stage digital health startups with healthcare, pharma, and investor champions for cancer care innovation.
- Ownership category
- akta.pro rank
CancerX Startup Accelerator industry classification
Industry- Product category
- Healthcare Innovation Accelerator
- NAICS
- Computer Systems Design and Related Services (54151)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Oncology Pathways & Precision Medicine Decision Support (HLACAGAH)
- akta.pro secondary industries
- Oncology Telemedicine Platforms (HLALAGAH), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where CancerX Startup Accelerator is headquartered
LocationHeadquarters
- HQ city
- Tampa
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
CancerX Startup Accelerator business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Operations, Technology or R&D
Revenue model
- Membership Fees: CancerX operates with membership tiers (Foundational Member, Premier Contributor, Thought Leader, Innovation Leader, Innovation Catalyst) that provide varying levels of access to events, insights reports, community forums, marketplace listings, and accelerator benefits. The organization is a public-private partnership hosted by Advocate Health and Moffitt Cancer Center.
- Federal Government Partnership: Launched in coordination with the Office of the Assistant Secretary for Technology Policy (ASTP) as part of the HHS InnovationX program. This public-private partnership model likely includes government funding and support.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Foundational Member - Access to public community, member events, insights reports, and community projects |
| Subscription | Annual | Premier Contributor - Enhanced benefits including unlimited team seats and marketplace listing |
| Subscription | Annual | Thought Leader - Premium thought leadership and speaking opportunities |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
CancerX Startup Accelerator product offering
Product offeringCore offering
CancerX operates an annual Accelerator program that matches early-stage digital health startups with champion organizations (health systems, life sciences firms, payors, and investors) for mentorship, education, funding access, and pilot opportunities. It complements this with the Constellation online community platform and specialized initiatives such as the Data Sprint (real-world oncology datasets) and the Financial Toxicity Initiative (digital tools for patient financial navigation in cancer care).
Product overview
CancerX is a public-private partnership that accelerates digital innovation in oncology through three interconnected pillars: an annual Accelerator program that provides mentorship, education, and funding access to early-stage startups; the Constellation virtual community platform for networking and collaboration; and Special Initiatives including Data Sprint and Financial Toxicity programs. The Accelerator Program is the core offering—a 4-month cohort-based program matching startups with champion organizations for mentorship and pilot opportunities. The Constellation serves as the community engagement platform providing members-only access to forums, events, and resources. Data Sprint and Financial Toxicity are specialized initiatives addressing data standards and patient financial burden respectively.
Differentiator
Problem solved
Functional benefit
Products and services
- CancerX Accelerator Program A flagship 4-month accelerator program that matches early-stage digital health startups with Champion organizations from health systems, life sciences, payors, and investors. Provides mentorship, education, funding access, and clinical partnership opportunities to startups developing solutions for cancer prevention, diagnosis, treatment, care coordination, and survivorship.
- CancerX Constellation A virtual online community providing oncology experts and healthcare leaders a private environment to network, collaborate, engage in discussion, and participate in CancerX Initiatives. Includes announcements, early access to reports, exclusive events, forum boards, marketplace listings, and thought leadership content.
- CancerX Data Sprint An initiative to build comprehensive real-world datasets in oncology through collaboration with federal government and industry. Works with CMMI, NCI, FDA, and ONC to advance cancer-related data standards and support implementation of USCDI+ Oncology data elements.
- Financial Toxicity Initiative A set of digital innovation resources including a Solutions Catalog, Core Competencies, Financial Navigation Guide, Digital Navigation ROI Calculator, and Digitally Enabled Patient Navigation Blueprint to help health systems address financial barriers in cancer care and reduce patient costs.
- CancerXpress A weekly educational curriculum offered within the Accelerator program, covering four tracks: working with health systems, working with industry, working with the public sector, and a speaker series on scaling business within oncology.
Quantifiable outcome
- 2024 inaugural cohort: 16 startups raised over $42M in venture funding, signed 9 contracts with health systems, 2+ investments secured, 234 individuals employed
- +3 more outcomes
Companies that use CancerX Startup Accelerator
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles4 records
CancerX Startup Accelerator technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
CancerX Startup Accelerator partnerships and signals
Strategic signalPartnerships
18 partnerships are on record, tiered core, major, flagship and minor.
- ClearwatercoreStrategic partnership to launch CancerX Cybersecurity Mark, Powered by Clearwater. Program prepares emerging oncology technologies to meet enterprise-grade security standards before deployment in health systems. Two-phase program: assessment (readiness evaluation, gap analysis, prioritized roadmap) and preparation (fractional vCISO support, managed security services, continuous monitoring).
- MedHaulmajorPartnership to release national report on transportation barriers in cancer care. MedHaul is a digital health and mobility platform coordinating medically appropriate transport for patients. Joint roundtable brought together cancer center executives, clinical trial operators, pharma partners and digital health innovators to address transportation challenges.
- Rush University System for HealthmajorNew Champion organization joining CancerX network for 2026 cohort. Provides mentorship, validation, and real-world insight to help accelerate startup learning, deployment and scale in clinical settings.
- Atlantic Health SystemmajorNew Champion organization joining CancerX network for 2026 cohort. Contributes to champion-startup matching process to help startups validate ideas and bring them to life in real-world care settings.
- AstraZenecamajorNew Champion organization joining CancerX network. VP Medical Excellence, Strategy & Operations (Shirin Ahmed) highlighted that championing CancerX aligns with their commitment to advancing oncology innovation through partnership, bringing together startups, health systems, and industry.
- NovartismajorNew Champion organization joining CancerX network for 2026 cohort. Industry partner that brings pharmaceutical expertise and potential investment opportunities to the accelerator ecosystem.
- KidsXcoreNationally recognized community of pediatric hospitals with 30+ member hospitals. Partnership creates unique opportunities for startups in pediatric oncology with 2 of 15 available spots in 2025 cohort reserved for pediatric oncology companies. KidsX provides additional tailored mentorship and programming.
- Advocate HealthflagshipOne of two founding anchor members of CancerX consortium. One of the nation's largest nonprofit health systems (third-largest in US) with 130 cancer locations including an NCI-designated Comprehensive Cancer Center. Serves as national steering partner and accelerator Champion, providing mentorship, pilot opportunities, and innovation ecosystem access.
- Moffitt Cancer CenterflagshipHost organization and founding home of CancerX. Only NCI-designated Comprehensive Cancer Center in Florida. Provides executive leadership (Xavier Avat as Executive Sponsor, Dr. Kamal Jethwani as CancerX Lead), operational support, and hosts annual Innovation Summit. Driving force behind CancerX mission since its inception two years ago.
- Office of the Assistant Secretary for Technology Policy (ASTP)coreFederal government partner within HHS. CancerX was launched in coordination with ASTP as part of the HHS InnovationX program launched in 2018. Provides government collaboration opportunities and policy alignment for CancerX initiatives.
- Office of the National Coordinator for Health Information Technology (ONC)coreFederal government partner collaborating on health IT standards. Partnered with CancerX Data Sprint initiative to support the ongoing collaboration between CMMI's Enhancing Oncology Model (EOM) and ONC's USCDI+ Oncology extension development.
- MassChallengemajorChampion organization providing startup support and resources. Major accelerator and innovation organization that contributes to the CancerX ecosystem with mentorship and program support.
- Dana-Farber Cancer InstitutemajorChampion organization and one of the nation's leading cancer research and treatment centers. Provides clinical expertise, mentorship, and potential pilot opportunities for accelerator startups.
- Memorial Sloan Kettering Cancer CentermajorChampion organization and one of the world's oldest private cancer centers. Digital Venture Lead Rick Peng highlighted CancerX's unique effectiveness in bringing together different stakeholders from across the healthcare ecosystem to coordinate innovation.
- MercuryminorChampion organization contributing to the 2025 accelerator program. Provides industry expertise and mentorship support for selected startups.
- Elevance HealthminorHealth insurance payor and Champion organization. Spencer Ward, Portfolio Director, represents Elevance Health on CancerX Steering Committee, bringing payer perspective to accelerator programming.
- Johnson & JohnsonmajorPharmaceutical company and Champion organization. Dr. Ashita S. Batavia, Head of Hematology & Oncology Data Sciences, serves on CancerX Steering Committee, providing industry leadership for the accelerator.
- InnsenaminorDigital health focused organization and Champion organization contributing to the 2025 accelerator program with industry expertise and mentorship.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
CancerX Startup Accelerator competitors and assessment
Company assessmentDirect peers
- MassChallenge HealthTech: Large global accelerator network with a dedicated HealthTech track. CancerX already lists MassChallenge as a Champion and the two compete for the same digital health startup pipeline and enterprise sponsors.
- StartX Med: Stanford-affiliated accelerator with a dedicated Med track. Comparable in mission (university/health system-anchored digital health accelerator) and competes for top oncology and digital health founders.
- Matter Health (Chicago): Chicago-based healthcare innovation hub and accelerator. Comparable accelerator model targeting the same cohort of digital health founders and enterprise healthcare sponsors in the Midwest — and CancerX already runs events in Chicago.
- Rock Health: Venture fund and digital health incubator supporting early-stage companies. Directly competes for digital health startup deal flow, particularly with enterprise partners in pharma and providers.
- KidsX: Pediatric digital health accelerator consortium of 30+ children's hospitals. Already a CancerX partner (reserving slots for pediatric oncology in 2025 cohort) and a directly comparable hospital-led accelerator model in an adjacent sub-vertical.
- Blueprint Health: Healthcare-focused accelerator supporting early-stage digital health companies. Direct comparator in cohort model, mentor network composition, and enterprise sponsor relationships.
Emerging players
- Jumpstart Health Investors: Healthcare-focused venture firm and accelerator. Targets the same early-stage digital health startup pool and competes for health system and corporate venture sponsorship.
Broad incumbents
- HHS InnovationX: Broader HHS innovation accelerator initiative under which CancerX sits. Provides shared infrastructure, policy alignment, and federal relationships but operates at a much larger scale across multiple disease areas.
- ARPA-H: Federal Advanced Research Projects Agency for Health, focused on cancer and other high-impact biomedical challenges. Functions as a much larger, federally funded peer in oncology innovation funding and program design that overlaps with CancerX's HHS InnovationX positioning.
- Mayo Clinic Platform / Mayo Innovation Exchange: Major US health system accelerator and innovation platform. Operates a similar accelerator-style model for digital health startups, providing validation, pilots, and clinical access — directly comparable Champion-style value proposition.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
CancerX Startup Accelerator financial estimates
Financial estimateRevenue estimate
Valuation estimate
CancerX Startup Accelerator leadership team
Management profileNumber of profiles
Profiles11 records
CancerX Startup Accelerator funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CancerX Startup Accelerator M&A and investment
M&A and investmentM&A
Investments40 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CancerX Startup Accelerator
What does CancerX Startup Accelerator do?
CancerX operates an annual Accelerator program that matches early-stage digital health startups with champion organizations (health systems, life sciences firms, payors, and investors) for mentorship, education, funding access, and pilot opportunities. It complements this with the Constellation online community platform and specialized initiatives such as the Data Sprint (real-world oncology datasets) and the Financial Toxicity Initiative (digital tools for patient financial navigation in cancer care).
Is CancerX Startup Accelerator a public or private company?
CancerX Startup Accelerator is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was CancerX Startup Accelerator founded?
CancerX Startup Accelerator was founded in 2023.
Where is CancerX Startup Accelerator based?
CancerX Startup Accelerator is headquartered in Tampa, United States, in the North America region.
How does CancerX Startup Accelerator make money?
Two revenue lines are on record. Membership Fees are the primary driver. The others are federal Government Partnership.
Who are CancerX Startup Accelerator's main competitors?
Direct peers on record are MassChallenge HealthTech, StartX Med, Matter Health (Chicago), Rock Health, KidsX and Blueprint Health. Jumpstart Health Investors is listed as an emerging player. Broad incumbents are HHS InnovationX, ARPA-H and Mayo Clinic Platform / Mayo Innovation Exchange.
Does CancerX Startup Accelerator have an API?
No public API is recorded for CancerX Startup Accelerator.
What industry is CancerX Startup Accelerator in?
CancerX Startup Accelerator's product category is Healthcare Innovation Accelerator. Its primary akta.pro industry code is HLACAGAH, Oncology Pathways & Precision Medicine Decision Support, with a secondary code of HLALAGAH, Oncology Telemedicine Platforms. Its NAICS code is 54151 and its SIC code is 8000.